Back to catalog
Tirzepatide 5mg vial — PeptideBazaar
Metabolic Research

Tirzepatide 5mg

Dual GIP/GLP-1 receptor agonist. Next-generation peptide for metabolic research with superior efficacy profiles.

Purity
≥98% (HPLC verified)
Dosage
2.5–15 mg/week
Key Benefits
  • Dual receptor agonist
  • Superior weight reduction
  • Insulin sensitivity
  • Lipid profile improvement
In Stock
₹7,999
≈ $95 USD
Research Use Only. This product is intended solely for in-vitro research. Not for human or animal consumption. Not approved by the FDA.